Target intelligence / Profile preview

Programmed death-ligand 1 mRNA 3' untranslated region (CD274 mRNA 3'UTR) (CD274 mRNA 3'UTR)

Target
CD274 mRNA 3'UTR
Molecular classification
mRNA, Regulatory RNA element, Other
01

Overview

The Programmed death-ligand 1 mRNA 3' untranslated region (CD274 mRNA 3'UTR) is a critical regulatory segment of the CD274 transcript that governs the stability and translation of the PD-L1 protein (Kataoka et al., Nature 2016). This region contains multiple binding sites for microRNAs (miRNAs), such as miR-513 and miR-200, and RNA-binding proteins (RBPs) like AUF1 and HuR, which normally suppress PD-L1 expression to maintain immune homeostasis (Wang et al., Gene 2017). In various cancers, including T-cell lymphomas and gastric cancer, the 3'UTR of CD274 is frequently truncated or mutated, leading to the loss of these inhibitory regulatory elements and subsequent massive overexpression of PD-L1, which facilitates immune evasion by the tumor (Kataoka et al., Nature 2016). Consequently, the CD274 mRNA 3'UTR has emerged as a novel therapeutic target for RNA-based interventions, including antisense oligonucleotides (ASOs) and small molecules designed to restore regulatory control or induce mRNA degradation (Coelho et al., Trends in Cancer 2017). Targeting this region offers a potential strategy to modulate the PD-1/PD-L1 axis at the post-transcriptional level, potentially overcoming resistance to traditional monoclonal antibody therapies (Mezzadra et al., Nature 2017).

Other names
PD-L1 mRNA 3'UTRB7-H1 mRNA 3'UTRCD274 3' untranslated regionPDCD1L1 mRNA 3'UTR
02

Mechanism of action

Modulation of mRNA stability and translation through recruitment of RNase H or steric hindrance of regulatory protein/miRNA binding to the 3' untranslated region.

03

Biological functions

Immune responsePost-transcriptional regulationmRNA stabilityTranslation regulationOther
04

Disease associations

CancerInfectionOther
05

Safety considerations

Immune-related adverse events (irAEs)Off-target RNA bindingSystemic inflammatory response to RNA-based therapeutics
06

Interacting drugs

Antisense oligonucleotides (ASOs)

2 more in the full profile.

07

Biomarkers

CD274 3'UTR structural variantsPD-L1 protein expression (IHC)CD274 mRNA levels

Beyond the preview

Go deeper on Programmed death-ligand 1 mRNA 3' untranslated region (CD274 mRNA 3'UTR) (CD274 mRNA 3'UTR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Programmed death-ligand 1 mRNA 3' untranslated region (CD274 mRNA 3'UTR) (CD274 mRNA 3'UTR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call